高级搜索
腋淋巴结阴性乳腺癌微血管密度与预后相关性研究[J]. 肿瘤防治研究, 1999, 26(4): 272-274.
引用本文: 腋淋巴结阴性乳腺癌微血管密度与预后相关性研究[J]. 肿瘤防治研究, 1999, 26(4): 272-274.
A Relative Study on Microvessel Density to Prognosis of Axillary-node Negative Breast Cancer[J]. Cancer Research on Prevention and Treatment, 1999, 26(4): 272-274.
Citation: A Relative Study on Microvessel Density to Prognosis of Axillary-node Negative Breast Cancer[J]. Cancer Research on Prevention and Treatment, 1999, 26(4): 272-274.

腋淋巴结阴性乳腺癌微血管密度与预后相关性研究

A Relative Study on Microvessel Density to Prognosis of Axillary-node Negative Breast Cancer

  • 摘要: 目的: 探讨微血管生成与腋淋巴结阴性乳腺癌(ANNBC)临床病理及预后关系。方法: 免疫组化方法检测120例ANNBC石蜡标本中微血管密度(MVD), 分析MVD与临床病理因素及无复发生存率(RFS)、无转移生存率(MFS)和总体生存率(OS)的关系。结果: MVD 平均值38.21±18.72, 与多种临床病理因素无关; 复发转移ANNBC MVD值显著高于无病生存者; 高MVD 组(MVD>38)OS 、RFS 、MFS 曲线低于低MVD组(MVD ≤38), 差异有统计学意义(P<0.5 或P <0.01)。结论: 微血管生成活跃ANNBC预后不良, MVD可能是ANNBC一种较好的预后因子。

     

    Abstract: Objective: To determine the relation of microvessel density (MVD)to the prognosis and the clinicopathological factors in axillary-node-negative breast cancer (ANNBC). Methods: MVD in 120 cases paraffin specimens of ANNBC. were examinated using imminohistochemistry technique. The relationship between MVD and overall survival (OS), relapsefree survival (RFS), metastasis-free survival (MFS) were analysed, respectively, as well as it was done between MVD and five clinicopathological factors. Results: The mean MVD was 38.21 ±18.72. It didn't relate to those clinicopathological factors. MVD in relapse and metastasis group which was apparently higher than that in desease-free group; OS, RFS, MFS curve in higher MVD group (MD >38) were significiantly lower those that in lower MVD group (MVD ≤38), respectively ; COX model indicated that MVD was an independent prognostic factor in ANNBC. Conclusion: MVD may be a good prognostic indicator for patients with ANNBC.

     

/

返回文章
返回